• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical Pathological Characteristics and Management Impact of Acute Respiratory Distress Syndrome Resulting from Influenza A (H1N1) Virus

tetano

Editor, Senior Moderator
South Med J. 2010 Jul 8. [Epub ahead of print]
Clinical Pathological Characteristics and Management Impact of Acute Respiratory Distress Syndrome Resulting from Influenza A (H1N1) Virus.

Homsi S, Milojkovic N, Homsi Y.

From the St. Edwards Mercy Medical Center, Fort Smith, AR; Sparks Medical Foundation, Fort Smith, AR; and Northeastern University and Massachusetts General Hospital, Boston, MA.
Abstract

Young adults, especially pregnant woman and patients with pre-existing medical conditions, appear to be at risk for the development of severe acute respiratory distress syndrome (ARDS) from influenza A (H1N1) infection, leading to critical hypoxemia. This may require high ventilator settings, the use of nonconventional modes, and extracorporeal membrane oxygenation in some cases. This severe ARDS may be related to prolonged and virulent viral infection, inducing ongoing aberrant immune responses and leading to extensive lung damage. Duration of antiviral therapy, the timing of steroid introduction, and moving away from standard ventilation techniques in ARDS may be key points in disease management.

PMID: 20622733 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20622733
 
Back
Top Bottom